As health-care professionals, we are entrusted with making sure that every compounded sterile preparation (CSP) is accurate and carries the lowest possible risk of contamination. It is preferred that CSPs are prepared in a pharmacy’s ISO-5 compounding suite. However, there are occasions when patient needs require us to prepare medications outside of those controlled settings. This course will take an in-depth look at the minimum requirements as well as the best practices for maintaining patient safety when sterile drugs are mixed in environments outside of a cleanroom. 

Learning Objectives: At the conclusion of this session, learners will be able to: 
• Define immediate-use compounding under USP <797> (2023)
• Identify and understand the seven criteria that qualify preparation as an immediate-use CSP, exempting it from full USP <797> requirements
• Describe best practices for reducing the risk of contamination when compounding for immediate use outside of ISO-5 conditions
• Explain the distinction between compounding and preparation by approved labeling

CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

Contact Hours: This session has been approved for 1 contact hour

Expiration date for receipt of contact hours: December 10, 2028

To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.